280 related articles for article (PubMed ID: 10675491)
1. Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer (review).
Aunoble B; Sanches R; Didier E; Bignon YJ
Int J Oncol; 2000 Mar; 16(3):567-76. PubMed ID: 10675491
[TBL] [Abstract][Full Text] [Related]
2. Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers.
Rhei E; Bogomolniy F; Federici MG; Maresco DL; Offit K; Robson ME; Saigo PE; Boyd J
Cancer Res; 1998 Aug; 58(15):3193-6. PubMed ID: 9699640
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathology of ovarian carcinomas.
Matias-Guiu X; Prat J
Virchows Arch; 1998 Aug; 433(2):103-11. PubMed ID: 9737787
[TBL] [Abstract][Full Text] [Related]
4. [Molecular genetics of ovarian cancer].
Yanaihara N; Okamoto A; Takakura S; Yamada K; Ochiai K; Tanaka T
Nihon Rinsho; 2004 Oct; 62 Suppl 10():441-8. PubMed ID: 15535284
[No Abstract] [Full Text] [Related]
5. [Recent developments in the molecular genetic understanding of ovarian carcinoma].
Shimizu Y
Nihon Rinsho; 2004 Oct; 62 Suppl 10():489-95. PubMed ID: 15535294
[No Abstract] [Full Text] [Related]
6. [Alterations of c-Myc and c-erbB-2 genes in ovarian tumours].
Pastor T; Popović B; Gvozdenović A; Boro A; Petrović B; Novaković I; Puzović D; Luković L; Milasin J
Srp Arh Celok Lek; 2009; 137(1-2):47-51. PubMed ID: 19370966
[TBL] [Abstract][Full Text] [Related]
7. Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group.
Pharoah PD; Easton DF; Stockton DL; Gayther S; Ponder BA
Cancer Res; 1999 Feb; 59(4):868-71. PubMed ID: 10029077
[TBL] [Abstract][Full Text] [Related]
8. [Genetic abnormalities in ovarian tumors].
Kiguchi K; Okuda Y; Kobayashi Y; Ishizuka B; Ohta T; Fukuda M
Nihon Rinsho; 2004 Oct; 62 Suppl 10():449-53. PubMed ID: 15535285
[No Abstract] [Full Text] [Related]
9. The molecular basis of ovarian cancer.
Gallion HH; Pieretti M; DePriest PD; van Nagell JR
Cancer; 1995 Nov; 76(10 Suppl):1992-7. PubMed ID: 8634990
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of p53 protein is frequent in ovarian cancers associated with BRCA1 and BRCA2 germline mutations.
Zweemer RP; Shaw PA; Verheijen RM; Ryan A; Berchuck A; Ponder BA; Risch H; McLaughlin JR; Narod SA; Menko FH; Kenemans P; Jacobs IJ
J Clin Pathol; 1999 May; 52(5):372-5. PubMed ID: 10560359
[TBL] [Abstract][Full Text] [Related]
11. [Genetic alterations in the genesis and development of ovarian cancer].
Okamoto A; Yokoyama S; Terashima Y
Gan To Kagaku Ryoho; 1992 Oct; 19(12):1971-6. PubMed ID: 1358031
[TBL] [Abstract][Full Text] [Related]
12. A high occurrence of BRCA1 and BRCA2 mutations among Czech hereditary breast and breast-ovarian cancer families.
Machácková E; Foretová L; Navrátilová M; Valík D; Claes K; Messiaen L
Cas Lek Cesk; 2000 Oct; 139(20):635-7. PubMed ID: 11192759
[TBL] [Abstract][Full Text] [Related]
13. Genetics and ovarian carcinoma.
Lynch HT; Casey MJ; Lynch J; White TE; Godwin AK
Semin Oncol; 1998 Jun; 25(3):265-80. PubMed ID: 9633840
[TBL] [Abstract][Full Text] [Related]
14. Genetic factors in ovarian carcinoma.
Li AJ; Karlan BY
Curr Oncol Rep; 2001 Jan; 3(1):27-32. PubMed ID: 11123866
[TBL] [Abstract][Full Text] [Related]
15. Biomarkers in the ovary.
Berchuck A
J Cell Biochem Suppl; 1995; 23():223-6. PubMed ID: 8747400
[TBL] [Abstract][Full Text] [Related]
16. Oncogenesis in ovarian cancer.
Børresen AL
Acta Obstet Gynecol Scand Suppl; 1992; 155():25-30. PubMed ID: 1502889
[TBL] [Abstract][Full Text] [Related]
17. [Familial ovarian cancer].
Sekine M; Tanaka K
Nihon Rinsho; 2000 Jul; 58(7):1409-12. PubMed ID: 10921314
[TBL] [Abstract][Full Text] [Related]
18. BRCA1 and BRCA2 mutations in central and southern Italian patients.
Ottini L; D'Amico C; Noviello C; Lauro S; Lalle M; Fornarini G; Colantuoni OA; Pizzi C; Cortesi E; Carlini S; Guadagni F; Bianco AR; Frati L; Contegiacomo A; Mariani-Costantini R
Breast Cancer Res; 2000; 2(4):307-10. PubMed ID: 11056688
[TBL] [Abstract][Full Text] [Related]
19. BRCA1 and BRCA2 in breast cancer families from Wales: moderate mutation frequency and two recurrent mutations in BRCA1.
Lancaster JM; Carney ME; Gray J; Myring J; Gumbs C; Sampson J; Wheeler D; France E; Wiseman R; Harper P; Futreal PA
Br J Cancer; 1998 Dec; 78(11):1417-20. PubMed ID: 9836472
[TBL] [Abstract][Full Text] [Related]
20. Gene expression and prognostic significance in ovarian cancer.
Tammela J; Odunsi K
Minerva Ginecol; 2004 Dec; 56(6):495-502. PubMed ID: 15729202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
